Summary
The Trump administration plans to announce a possible link between autism and the use of Tylenol during pregnancy, though scientific research has not proven this connection. They also propose using a form of vitamin B, leucovorin, as a potential treatment for autism. Scientific communities have challenged these claims, emphasizing the established role of genetics in autism and the continued recommendation for acetaminophen use during pregnancy.
Key Facts
- The Trump administration claims there may be a link between acetaminophen use in pregnancy and autism risk.
- Scientific research has not found a conclusive link between acetaminophen and autism.
- Leucovorin, a form of vitamin B, is suggested as a potential autism treatment by the administration.
- Genetic factors are widely accepted as a significant risk for autism.
- Acetaminophen is still recommended for treating fever and pain in pregnant women by medical groups.
- Small studies have suggested a possible association, but the largest study found no increased risk.
- The Autism Science Foundation acknowledges limited studies on folate levels affecting autism risk.
